Here we show the feasibility of using an automated workcell for the culture and monitoring of 3D pulmonary (lung) organoids. These results provide the foundational workflow which can be adapted for other 3D cell models such as intestinal, brain or patient-derived tissues and enable scaling-up of organoid production for other downstream applications.